223 related articles for article (PubMed ID: 19369702)
21. Thioredoxin overexpression modulates remodeling factors in stress responses to cigarette smoke.
Huang YL; Chuang CY; Sung FC; Chen CY
J Toxicol Environ Health A; 2008; 71(22):1490-8. PubMed ID: 18836924
[TBL] [Abstract][Full Text] [Related]
22. Enhanced 7-ethyl-10-hydroxycamptothecin (SN-38) lethality by methylselenocysteine is associated with Chk2 phosphorylation at threonine-68 and down-regulation of Cdc6 expression.
Yin MB; Li ZR; Cao S; Durrani FA; Azrak RG; Frank C; Rustum YM
Mol Pharmacol; 2004 Jul; 66(1):153-60. PubMed ID: 15213307
[TBL] [Abstract][Full Text] [Related]
23. Thioredoxin-deficient mice, a novel phenotype sensitive to ambient air and hypersensitive to hyperoxia-induced lung injury.
Das KC
Am J Physiol Lung Cell Mol Physiol; 2015 Mar; 308(5):L429-42. PubMed ID: 25539854
[TBL] [Abstract][Full Text] [Related]
24. Redox regulation of the tumor suppressor PTEN by the thioredoxin system and cumene hydroperoxide.
Han SJ; Zhang Y; Kim I; Chay KO; Yoon HJ; Jang DI; Yang SY; Park J; Woo HA; Park I; Lee SR
Free Radic Biol Med; 2017 Nov; 112():277-286. PubMed ID: 28774816
[TBL] [Abstract][Full Text] [Related]
25. Kaempferol induces apoptosis in glioblastoma cells through oxidative stress.
Sharma V; Joseph C; Ghosh S; Agarwal A; Mishra MK; Sen E
Mol Cancer Ther; 2007 Sep; 6(9):2544-53. PubMed ID: 17876051
[TBL] [Abstract][Full Text] [Related]
26. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1.
Saitoh M; Nishitoh H; Fujii M; Takeda K; Tobiume K; Sawada Y; Kawabata M; Miyazono K; Ichijo H
EMBO J; 1998 May; 17(9):2596-606. PubMed ID: 9564042
[TBL] [Abstract][Full Text] [Related]
27. Knockdown of Chk1 sensitizes human colon carcinoma HCT116 cells in a p53-dependent manner to lidamycin through abrogation of a G2/M checkpoint and induction of apoptosis.
Pan Y; Ren KH; He HW; Shao RG
Cancer Biol Ther; 2009 Aug; 8(16):1559-66. PubMed ID: 19502782
[TBL] [Abstract][Full Text] [Related]
28. Thioredoxin-dependent redox regulation of p53-mediated p21 activation.
Ueno M; Masutani H; Arai RJ; Yamauchi A; Hirota K; Sakai T; Inamoto T; Yamaoka Y; Yodoi J; Nikaido T
J Biol Chem; 1999 Dec; 274(50):35809-15. PubMed ID: 10585464
[TBL] [Abstract][Full Text] [Related]
29. Up-Regulation Thioredoxin Inhibits Advanced Glycation End Products-Induced Neurodegeneration.
Ren X; Wang NN; Qi H; Qiu YY; Zhang CH; Brown E; Kong H; Kong L
Cell Physiol Biochem; 2018; 50(5):1673-1686. PubMed ID: 30384364
[TBL] [Abstract][Full Text] [Related]
30. Activation of the AMPK-FOXO3 pathway reduces fatty acid-induced increase in intracellular reactive oxygen species by upregulating thioredoxin.
Li XN; Song J; Zhang L; LeMaire SA; Hou X; Zhang C; Coselli JS; Chen L; Wang XL; Zhang Y; Shen YH
Diabetes; 2009 Oct; 58(10):2246-57. PubMed ID: 19592618
[TBL] [Abstract][Full Text] [Related]
31. Hexavalent chromium causes the oxidation of thioredoxin in human bronchial epithelial cells.
Myers JM; Antholine WE; Myers CR
Toxicology; 2008 Apr; 246(2-3):222-33. PubMed ID: 18328613
[TBL] [Abstract][Full Text] [Related]
32. Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy.
Tonissen KF; Di Trapani G
Mol Nutr Food Res; 2009 Jan; 53(1):87-103. PubMed ID: 18979503
[TBL] [Abstract][Full Text] [Related]
33. A thioredoxin reductase and/or thioredoxin system-based mechanism for antioxidant effects of ambroxol.
Huang J; Xu J; Tian L; Zhong L
Biochimie; 2014 Feb; 97():92-103. PubMed ID: 24103200
[TBL] [Abstract][Full Text] [Related]
34. Thioredoxin system in cell death progression.
Lu J; Holmgren A
Antioxid Redox Signal; 2012 Dec; 17(12):1738-47. PubMed ID: 22530689
[TBL] [Abstract][Full Text] [Related]
35. CHK1 and CHK2 are differentially involved in mismatch repair-mediated 6-thioguanine-induced cell cycle checkpoint responses.
Yan T; Desai AB; Jacobberger JW; Sramkoski RM; Loh T; Kinsella TJ
Mol Cancer Ther; 2004 Sep; 3(9):1147-57. PubMed ID: 15367709
[TBL] [Abstract][Full Text] [Related]
36. p53 regulates cellular responses to environmental carcinogen benzo[a]pyrene-7,8-diol-9,10-epoxide in human lung cancer cells.
Xiao H; Singh SV
Cell Cycle; 2007 Jul; 6(14):1753-61. PubMed ID: 17630511
[TBL] [Abstract][Full Text] [Related]
37. Thioredoxin and protein kinases in redox signaling.
Fujino G; Noguchi T; Takeda K; Ichijo H
Semin Cancer Biol; 2006 Dec; 16(6):427-35. PubMed ID: 17081769
[TBL] [Abstract][Full Text] [Related]
38. Lipid raft-mediated uptake of cysteine-modified thioredoxin-1: apoptosis enhancement by inhibiting the endogenous thioredoxin-1.
Kondo N; Ishii Y; Kwon YW; Tanito M; Sakakura-Nishiyama J; Mochizuki M; Maeda M; Suzuki S; Kojima M; Kim YC; Son A; Nakamura H; Yodoi J
Antioxid Redox Signal; 2007 Sep; 9(9):1439-48. PubMed ID: 17627472
[TBL] [Abstract][Full Text] [Related]
39. Stable suppression of the R2 subunit of ribonucleotide reductase by R2-targeted short interference RNA sensitizes p53(-/-) HCT-116 colon cancer cells to DNA-damaging agents and ribonucleotide reductase inhibitors.
Lin ZP; Belcourt MF; Cory JG; Sartorelli AC
J Biol Chem; 2004 Jun; 279(26):27030-8. PubMed ID: 15096505
[TBL] [Abstract][Full Text] [Related]
40. Oxidative inactivation of thioredoxin as a cellular growth factor and protection by a Cys73-->Ser mutation.
Gasdaska JR; Kirkpatrick DL; Montfort W; Kuperus M; Hill SR; Berggren M; Powis G
Biochem Pharmacol; 1996 Dec; 52(11):1741-7. PubMed ID: 8986137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
